Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16724864 | 0.84 | TSHR (0.48) | TSHR | |
| SCHEMBL246846 | 0.79 | — | — | |
| SCHEMBL556892 | 0.77 | — | — | |
| SCHEMBL28670030 | 0.76 | TSHR (0.33) | TSHR | |
| SCHEMBL14532416 | 0.75 | TSHR (0.43) | TSHR | |
| SCHEMBL10873783 | 0.75 | — | — | |
| SCHEMBL1580028 | 0.75 | TSHR (0.43) | TSHR | |
| SCHEMBL5712116 | 0.73 | TSHR (0.42) | TSHR | |
| SCHEMBL387611 | 0.71 | TSHR (0.40) | TSHR | |
| SCHEMBL235280 | 0.71 | TSHR (0.40) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230312617-A1 | PROCESS FOR SYNTHESIS OF ORGANOSILICON COMPOUNDS FROM HALOSILANES | MOMENTIVE PERFORMANCE MATERIALS INC. | 2023-10-05 | — | — | US | disclosed |
| CN-116829565-A | Method for synthesizing organosilicon compounds from halosilanes | 迈图高新材料公司 | 2023-09-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230312617-A1 | PROCESS FOR SYNTHESIS OF ORGANOSILICON COMPOUNDS FROM HALOSILANES | SP1, ZRANB2, CTCF | TSHR 3638/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.